U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748338) titled 'Ustekinumab Real World Evidence Study' on Jan. 25, 2021.
Brief Summary: The purpose of this study is to capture the real-world experience of CD patients treated with ustekinumab as part of their clinical care in a variety of care settings from large teaching/research centres to smaller district hospitals.
Study Start Date: Oct. 30, 2019
Study Type: OBSERVATIONAL
Condition:
Crohn's Disease
Intervention:
DRUG: Ustekinumab
Intravenous baseline, subcutaneous follow ups.
Recruitment Status: COMPLETED
Sponsor: University Hospital Southampton NHS Foundation Trust
Published by HT Digital Content Services with permission from Health...